Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday (CONTINUITY)

Clalit Health Services

Status: Unknown

Conditions: Osteoporosis

Treatments: Other: Questionnaires about compliance and persistence with bisphosphonates treatment

Study type: Observational

Funder types: Other

Identifiers

NCT01854086

MMC130009-13CTIL

Details and patient eligibility

About

The purpose of the study is to provide information about the rate of response and persistence to drug therapies for osteoporosis. Another issue examined in this study refers to the preferences and concerns about future treatments in patients during "drug holiday".

Enrollment: 150 estimated patients

Sex: Female

Ages: 40 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Postmenopausal women
• Diagnosis of osteoporosis in the medical record
• At least one prescription drug to treat osteoporosis in the last 5 years
• Insured by "Clalit" Health Services
• Hebrew-speaking capability and readiness to answer a questionnaire

Exclusion criteria

• Premenopausal women
• No diagnosis of osteoporosis in the medical record
• No treatment for osteoporosis in the last 5 years
• Women who do not speak Hebrew or are unable to answer a questionnaire

Trial design

150 participants in 1 patient group

Postmenopausal women

Description:

Postmenopausal women treated with bisphosphonates

Treatment:

Other: Questionnaires about compliance and persistence with bisphosphonates treatment